FDA

News and Updates by the Food and Drugs Administration (FDA)

Vaxcyte Initiates Phase 2 Trial for VAX-31 in Healthy Infants to Combat Invasive Pneumococcal Disease

Vaxcyte Inc, a pioneering company at the forefront of vaccine development, has revealed the commencement of its phase 2 trial for VAX-31 in healthy infants. This marks an important milestone as the first participants have received their initial doses. The

Vaxcyte Initiates Phase 2 Trial for VAX-31 in Healthy Infants to Combat Invasive Pneumococcal Disease Read More »

Neuranics Secures $700,000 in Seed Funding Round Headed by Inflection Point Ventures

Neuranics, a trailblazer in healthcare diagnostics, has garnered $700,000 in seed funding, predominantly supported by Inflection Point Ventures (IPV). These resources are earmarked for advancing their technological capabilities and clinical validations, propelling the startup on its journey to transform blood

Neuranics Secures $700,000 in Seed Funding Round Headed by Inflection Point Ventures Read More »

KPMG Study Reveals Life Sciences CEOs Optimistic About Growth and AI Investment Amid Economic Hurdles

KPMG’s recent study sheds light on the confidence life sciences CEOs hold regarding their company’s growth, even amidst dwindling belief in the industry, economic volatility, and AI implementation challenges, alongside net zero objectives. The KPMG 2024 Life Sciences CEO Outlook,

KPMG Study Reveals Life Sciences CEOs Optimistic About Growth and AI Investment Amid Economic Hurdles Read More »

NIIMS Medical College Celebrates Successful Conclusion of GENOME 2024: A Three-Day Multicultural Event

The Noida International Institute of Medical Sciences (NIIMS) recently announced the triumphant wrap-up of GENOME 2024, a vibrant three-day multicultural festivity crafted by fourth-year students from the 2020 batch. This event aimed to highlight the artistic flair, talents, and transition

NIIMS Medical College Celebrates Successful Conclusion of GENOME 2024: A Three-Day Multicultural Event Read More »